Trials / Sponsors / Naoyuki G. Saito, M.D., Ph.D.
Naoyuki G. Saito, M.D., Ph.D.
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia | Phase 1 / Phase 2 | 2023-10-01 |
| Terminated | IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia | Phase 1 | 2018-08-29 |